Abstract
The development of a multilevel "electronic doctor's assistant" for identifying immunologically compromised persons and the choice of optimal differentiated immunotherapy for pyo-inflammatory and other diseases is outlined.
Highlights
Pre-Laboratory AnalysisI. Introduction a) Identification of immunocompromised persons by the method of pre-laboratory analysis
Introduction a) Identification of immunocompromised persons by the method of pre-laboratory analysisOne of the achievements of modern medicine is the development of principles for prescribing immunotherapy to patients, consisting of assessing the immune status, verifying the diagnosis of the underlying disease, comparing the signaling mechanisms of pathology and targets of the modulator, and testing the correction option in practice
Legend: СU- conventional units; PhI, PN - phagocytic index and number, other designations - see above d) Detailed immunotherapy It is carried out without taking into account the nature of the disease.[13]
Summary
I. Introduction a) Identification of immunocompromised persons by the method of pre-laboratory analysis. One of the achievements of modern medicine is the development of principles for prescribing immunotherapy to patients, consisting of assessing the immune status, verifying the diagnosis of the underlying disease, comparing the signaling mechanisms of pathology and targets of the modulator, and testing the correction option in practice.
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call